FLT3 Inhibitors in AML

被引：0
|
作者：
Stone, R. M. [1 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Adult Leukemia Program, Boston, MA 02115 USA
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [21] MLL-menin and FLT3 inhibitors team up for AML
    Perl, Alexander E.
    BLOOD, 2020, 136 (21) : 2369 - 2370
  • [22] Beyond midostaurin: Which are the most promising FLT3 inhibitors in AML?
    Wang, Eunice S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [23] Analysis of flt3 in Adult AML
    Adnan, Shady
    Kandeel, Eman Z.
    Ghareeb, Mohammed
    Eldessouki, Ihab A.
    BLOOD, 2015, 126 (23)
  • [24] FLT3 gene mutations in AML
    Mills, KI
    Gilkes, AF
    Walsh, V
    Sweeney, M
    Austin, SJ
    Gale, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 29 - 29
  • [25] Role of Biomarkers in FLT3 AML
    Wei, Jiao
    Hui, Ai-Min
    Nitika
    CANCERS, 2022, 14 (05)
  • [26] FLT3 Mutant to Wild Type Allelic Ratio and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML.
    Levis, Mark
    Sato, Takashi
    Murphy, Kathleen
    Rajkhowa, Trivikram
    Pratz, Keith
    BLOOD, 2009, 114 (22) : 684 - 684
  • [27] MECHANISM OF FLT3 LIGAND DEPENDENT RESISTANCE TO FLT3 INHIBITORS
    Chen, Fangli
    Ishikawa, Yuichi
    Kihara, Rika
    Naoe, Tomoki
    Kiyoi, Hitoshi
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S57 - S57
  • [28] Mechanism of FLT3 Ligand Dependent Resistance to FLT3 Inhibitors
    Chen, Fangli
    Ishikawa, Yuichi
    Kiyoi, Hitoshi
    Naoe, Tomoki
    BLOOD, 2014, 124 (21)
  • [29] Molecular mechanisms underlying dual resistance to FLT3 inhibitors in AML cells
    Katayama, Kazuhiro
    CANCER SCIENCE, 2022, 113 : 1046 - 1046
  • [30] Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors
    Schwartz, Gregory W.
    Manning, Bryan
    Zhou, Yeqiao
    Velu, Priya
    Bigdeli, Ashkan
    Astles, Rachel
    Lehman, Anne W.
    Morrissette, Jennifer J. D.
    Perl, Alexander E.
    Li, Mingyao
    Carroll, Martin
    Faryabi, Robert B.
    CLINICAL CANCER RESEARCH, 2019, 25 (02) : 573 - 583
12345